Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Episenta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Episenta 300mg modified-release capsules
0408010W0BIACBR
|
Episenta | Sodium valproate | Central Nervous System | 4,257 |
|
Episenta 500mg modified-release granules sachets
0408010W0BIADBS
|
Episenta | Sodium valproate | Central Nervous System | 1,496 |
|
Episenta 1000mg modified-release granules sachets
0408010W0BIAEBT
|
Episenta | Sodium valproate | Central Nervous System | 1,294 |
|
Episenta 150mg modified-release capsules
0408010W0BIABBQ
|
Episenta | Sodium valproate | Central Nervous System | 1,210 |
|
Episenta 300mg/3ml solution for injection ampoules
0408010W0BIAABP
|
Episenta | Sodium valproate | Central Nervous System | 13 |
|
Episenta 1g/10ml solution for injection ampoules
0408010W0BIAFBU
|
Episenta | Sodium valproate | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.